The Company in a Nutshell
| Date Reviewed | 08/24/2025 |
| Company Name | International Flavors & Fragrances Inc |
| Symbol | IFF |
| Sector | Materials |
| Industry | Specialty Chemicals |
| Beta | 1.04 |
| PRO Rating | 2 |
| Dividend Safety | 1 |
Business Model
International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage, health and biosciences, scent, and complementary adjacent products. The Company's segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as soy and pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.
| Current price | 61.93 |
| ROE | 1.70 % |
| ROIC | 4.15 % |
| Shareholder Yield | 0.50 % |
| 5-Yr Total Return | -39.10 % |
| 1-Yr Total Return | -40.15 % |
| Next Earnings Date | 11-04-25 |
Latest Quarter Information
What the CEO said:
Erik Fyrwald, CEO of IFF, said:
“Our teams delivered top-line growth and improved profitability, driven by disciplined execution and a strong focus on productivity. We made strides in reshaping our portfolio and reducing leverage to 2.5×, while continuing to invest in our highest-return businesses to drive sustainable growth.”
What we say:
2025-08-23, International Flavors & Fragrances Inc reported a mixed quarter performance on EPS and revenue with +260.6% and -4.3% respectively. Revenue declined due to divestitures that reduced the sales base. EPS rose mainly from one-time gains on divestitures. Adjusted EBITDA hit $552M with a 20% margin, up 6% currency-neutral. IFF completed sales of Pharma Solutions and Nitrocellulose and agreed to divest soy crush, concentrates, and lecithin to focus on higher-margin areas. Management reaffirmed 2025 guidance: $10.6–$10.9B sales (1–4% growth) and $2.0–2.15B adjusted EBITDA (5–10% growth).
Investment Thesis
Dividend Triangle
| 5-Yr Rev. Growth | 17.25 % |
| 5-Yr EPS Growth | 0.00 % |
| 5-Yr Div Growth | -11.95 % |
Potential Risks
| Debt/Equity | 0.65 |
| Financial Debt to EBITDA (TTM) | 2.85 |
| Current Ratio (Quarterly) | 1.85 |
| Credit Score | 41 |
Dividend Growth Perspective
| Dividend ($) | 1.6 |
| Dividend Yield Fwd | 2.60 % |
| Dividend Frequency | Quarterly |
| Average 5-Yr Yield | 2.75 % |
| Payout Ratio (%) | 168.30 |
| Cash Payout Ratio (%) | 73.05 |
| DGR 1-Yr | -20.40 |
| DGR 3-Yr | -20.45 |
| DGR 5-Yr | -11.95 |
| DGR Streak | 21 |
| Chowder Score | -9.35 |
| Next DVD PMT | 10-10-25 |
Valuation
(Data for `ddm_growth_rate_years` field are missing to build DDM tables)
Video Tutorial: How to Read the Stock Cards DDM Valuation
| Market Cap | 16 B |
| PE Ratio | 0.00 |
| Fwd PE | 13.95 |
| Price to Book Ratio | 1.10 |
| DDM Valuation | 0 |
| Average 5-Yr PE | 210.63 |
| Value Score | 63 |